- International private healthcare operator NMC Health saw a jump in first-half earnings, driven by its healthcare division, as it confirmed the full-year guidance issued in May.

Earnings (EBITDA) rose 22.5% to £276.3m in the six months to 30 June 2019 while revenue climbed 32.6% to $1,236m.

While its healthcare division continued to be the most significant growth driver, supported by 2018 acquisitions, growth in its distribution business exceeded the guidance of 8-9% growth.

'NMC Health again achieved strong performance in the first six months of the year, as we continue to deliver on our growth strategy in our attractive target markets. Our ability to perform strongly in a challenging environment is testament to NMC's strategy of developing niche, differentiated verticals in our core markets that provide the best possible care for our patients,' said CEO Prasanth Manghat.

The company said it remained on track to meet its full-year guidance of $575-585m for EBITDA and $2,500-2,540m for revenue, adding that it was 'highly confident' of its future performance.

The company also said it planned to start the process to request shareholder approval for a share buyback programme.

If approved, the programme would only be employed 'opportunistically' to take advantage of exceptional price volatility and would be limited to a maximum of £200m.

At 8:21am: [LON:NMC] NMC Health PLC share price was +694.5p at 2630.5p

Story provided by